Nolato
Nolato AB is a Swedish polymer technology company engaged in the development and high-volume manufacturing of specialized polymer components and systems. The company operates through three primary business areas: Medical Solutions, developing plastic components and drug delivery devices for pharma and diagnostics; Engineered Solutions, producing polymer components for industrial and automotive applications; and Industrial Solutions. Its product suite encompasses insulin pens, asthma inhalers, diagnostic consumables, automotive shielding, and precision industrial molded parts. Principal revenue is generated from contract manufacturing sales of polymer components, specialized toolmaking fees, and precision assembly services for enterprise clients globally. Nolato holds a strong international market position as a specialized polymer developer and supplier to biopharmaceutical, medical technology, and industrial corporations. Headquartered in Torekov, Sweden, the company's Class B common stock is publicly listed and traded on Nasdaq Stockholm under the ticker NOLA B.
19 of the funds FundTelligence covers report a position in Nolato.
- Legal name
- Nolato AB
- Sector
- Industrials
- Country
- Sweden
- Funds holding it
- 19
Funds holding Nolato
- D&G Småbolag — Carnegie · 5.14 % (full portfolio disclosed, June 2026)
- ODIN Small Cap — ODIN · 3.6 % (full portfolio disclosed, September 2026)
- Case All Star Småbolag — Case · 3.55 % (full portfolio disclosed, June 2026)
- Nordea Nordic Small Cap — Nordea Funds · 3.18 % (full portfolio disclosed, July 2026)
- Nordea Nordic Small Cap Fund — Nordea Funds · 3.18 % (full portfolio disclosed, July 2026)
- Aktie-Ansvar Sverige — Aktie-Ansvar · 3.13 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Smaller Companies — Schroders · 2.87 % (full portfolio disclosed, June 2026)
- PriorNilsson Småbolag — PriorNilsson · 2.29 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 19 funds holding it.